Gentium Srl (GENTY) Stock Price, News & Analysis

Company Overview

Gentium S.r.l. is an Italian pharmaceutical company focused on developing and commercializing therapies for serious and rare medical conditions. The company is best known for defibrotide, a medicine used to treat hepatic veno-occlusive disease, also known as sinusoidal obstruction syndrome, a potentially life-threatening complication that can occur following hematopoietic stem-cell transplantation.

Defibrotide was developed and manufactured in Italy and marketed in Europe under the brand name Defitelio. The treatment later received approval in the United States, where it was commercialized by Jazz Pharmaceuticals. Gentium’s activities have therefore been centered on specialty pharmaceuticals serving patients and healthcare providers in European and international markets.

Gentium was established in Italy and became a publicly traded company before being acquired by Jazz Pharmaceuticals in 2014. Following that transaction, Gentium became part of Jazz Pharmaceuticals’ operations, and information about the company’s independent leadership and current standalone activities is limited.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: N/A
• Average Volume: 6,528 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: N/A
• Industry: N/A
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:GENTY
• CIK: N/A
• Web: www.gentium.com
• Phone: +39-31-5373200
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A